ABX196 in Combination With Nivolumab in Patients With Hepatocellular Carcinoma (clinicaltrials.gov) - Sep 30, 2026 - P1/2 | N=10 | Completed | Sponsor: Abivax S.A. | Recruiting ➔ Completed | N=48 ➔ 10
Enrollment change • Trial completion • Hepatocellular Cancer • Oncology • Solid Tumor
|